Greetings from MyCancerHaven!
We wanted to update you on our recent activities.
Here are the latest posts last week:
Blogs :
Referral for CAR T Therapy Should Always Be Considered in Relapsed/Refractory Multiple Myeloma
Dr. Lonial Discusses Characterizing Multiple Myeloma Subtypes in the CoMMpass Study
Enhancing CML Management for an Optimal Patient Journey
Latest Developments in Novel and Cellular Therapies for Patients With R/R Multiple Myeloma
Current trials and broader impact of GPRC5D-targeted therapies in multiple myeloma.
Summary of Long-term Follow-up from the MonumenTAL-1 Study
Dr. Banerjee discusses dose modification studies' impact on multiple myeloma.
The Efficacy and Treatment-Free Interval Benefits Support Earlier Use of CAR T Therapy in RR
Emerging Laboratory Monitoring Techniques and Key Insights for Heavily Pre-Treated RR
Broader Implications and Ongoing Trials of GPRC5D-Targeted Therapies in RR MM
Improved lab monitoring for advanced multiple myeloma.
Also at MCH the News and Tweets never stop flowing!
Join Us at www.mycancerhaven.org
The Team @ MCH
Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok
Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.
We wanted to update you on our recent activities.
Here are the latest posts last week:
Blogs :
Referral for CAR T Therapy Should Always Be Considered in Relapsed/Refractory Multiple Myeloma
Dr. Lonial Discusses Characterizing Multiple Myeloma Subtypes in the CoMMpass Study
Enhancing CML Management for an Optimal Patient Journey
Latest Developments in Novel and Cellular Therapies for Patients With R/R Multiple Myeloma
Current trials and broader impact of GPRC5D-targeted therapies in multiple myeloma.
Summary of Long-term Follow-up from the MonumenTAL-1 Study
Dr. Banerjee discusses dose modification studies' impact on multiple myeloma.
The Efficacy and Treatment-Free Interval Benefits Support Earlier Use of CAR T Therapy in RR
Emerging Laboratory Monitoring Techniques and Key Insights for Heavily Pre-Treated RR
Broader Implications and Ongoing Trials of GPRC5D-Targeted Therapies in RR MM
Improved lab monitoring for advanced multiple myeloma.
Also at MCH the News and Tweets never stop flowing!
Join Us at www.mycancerhaven.org
The Team @ MCH
Follow us on Facebook, Twitter (@My_Cancer_Haven), Instagram, YouTube, LinkedIn and TikTok
Note: Please do not reply to this e-mail as it is sent from an account that is not monitored. You can contact us by e-mail at contact@mycancerhaven.org.
